AONN+ Policy and Advocacy Committee Kicks Off 2023 by Supporting Two Cancer Leadership Council Letters

Press Releases published on March 3, 2023 in News & Updates

The Academy of Oncology Nurse & Patient Navigators’ (AONN+) Policy and Advocacy Committee kicked off 2023 by supporting two Cancer Leadership Council letters. The first was related to the Notice of Benefit and Payment Parameters (NBPP) for 2024, and the second focused on the Essential Health Benefits (EHB) in the Affordable Care Act.

Specifically, the NBPP addresses:

  • Network adequacy
  • Prohibition of midyear terminations for dependent children who turn 26
  • Special enrollment periods
  • Standardized plan options
  • Drugs classified as “non-essential” health benefits
Read First Letter

The EHB in the Affordable Care Act addresses:

  • Benefit descriptions in EHB-benchmark plan documents
  • Typical employer plans
  • A review of EHB
  • Coverage of prescription drugs as EHB
Read Second Letter

About the Academy of Oncology Nurse & Patient Navigators, Inc. (AONN+)
The Academy of Oncology Nurse & Patient Navigators, Inc. (AONN+), is the largest national specialty organization dedicated to improving patient care and quality of life by defining, enhancing, and promoting the role of oncology nurse and patient navigators. The organization, which has more than 9,000 members, was founded in 2009 to provide a network for all professionals involved and interested in patient navigation and survivorship care services in order to better manage the complexities of the cancer treatment process. www.aonnonline.org

For Immediate Release
Gwen Coverdale, 267-884-6328
This email address is being protected from spambots. You need JavaScript enabled to view it.

Related Items
AONN+'s ER+ Premenopausal Breast Cancer Journey Pathway Wins PM360 Pharma Choice Award
Press Releases published on February 28, 2024 in News & Updates
Cranbury, NJ (February 28, 2024)—The Academy of Oncology Nurse & Patient Navigators (AONN+) is pleased to share that PM360, a leading trade magazine for marketing decision-makers in the pharmaceutical, biotech, medical device, and diagnostic industries, has named AONN+’s estrogen-receptor-positive (ER+) Premenopausal Breast Cancer Journey Pathway, supported by TerSera Therapeutics, as the Pharma Choice Award – Variety Silver Winner.
The Academy of Oncology Nurse & Patient Navigators (AONN+) Selects Sites to Participate in National Acuity Quality Initiative
Press Releases published on October 4, 2023 in News & Updates
CRANBURY, NJ (Oct. 4, 2023) – The Academy of Oncology Nurse & Patient Navigators’ (AONN+) National Navigation Acuity Taskforce is developing a standardized, validated, evidence-based Navigation Acuity Tool for oncology navigation programs. When finalized, the acuity tool is expected to help oncology navigators characterize the intensity of the patient navigation workload, aid in the allocation of resources, and measure the effectiveness of navigation on patient outcomes.
The Academy of Oncology Nurse & Patient Navigators (AONN+) Announces New Leadership Council Members
Press Releases published on August 16, 2023 in News & Updates
CRANBURY, NJ—Each year, the AONN+ Leadership Council strives to bring novel ideas and perspectives to the table through the addition of new members.